We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$30.3M
AUM Growth
+$2.41M
Cap. Flow
-$25.8K
Cap. Flow %
-0.09%
Top 10 Hldgs %
35.76%
Holding
38
New
1
Increased
12
Reduced
10
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Financials 22.22%
3 Industrials 12.93%
4 Technology 11.63%
5 Consumer Staples 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
1
Bank of America
BAC
$435B
$1.2M 3.97%
77,186
-900
-1% -$13.4K
HON icon
2
Honeywell
HON
$77B
$1.17M 3.85%
14,201
+323
+2% +$25.2K
AAPL icon
3
Apple
AAPL
$4.54T
$1.15M 3.79%
57,344
-560
-1% -$10.6K
JNJ icon
4
Johnson & Johnson
JNJ
$618B
$1.11M 3.67%
12,145
-15
-0.1% -$1.38K
MKL icon
5
Markel Group
MKL
$23.3B
$1.09M 3.59%
+1,875
New +$1.02M
JPM icon
6
JPMorgan Chase
JPM
$935B
$1.07M 3.52%
18,268
+265
+1% +$14.5K
PFE icon
7
Pfizer
PFE
$143B
$1.05M 3.47%
36,246
+8,205
+29% +$239K
UNH icon
8
UnitedHealth
UNH
$376B
$1.04M 3.42%
13,785
+345
+3% +$24.8K
FLR icon
9
Fluor
FLR
$7.01B
$982K 3.24%
12,230
PG icon
10
Procter & Gamble
PG
$336B
$981K 3.24%
12,056
-100
-0.8% -$8.15K
QCOM icon
11
Qualcomm
QCOM
$155B
$962K 3.17%
12,960
DEO icon
12
Diageo
DEO
$49B
$957K 3.16%
7,229
EMR icon
13
Emerson Electric
EMR
$83.9B
$952K 3.14%
13,560
+1,050
+8% +$70.1K
YUM icon
14
Yum! Brands
YUM
$41.8B
$947K 3.12%
17,415
INTC icon
15
Intel
INTC
$455B
$946K 3.12%
36,442
+615
+2% +$14.9K
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.1T
$940K 3.1%
7,925
-200
-2% -$23.1K
ELV icon
17
Elevance Health
ELV
$81.5B
$935K 3.09%
10,125
+1,475
+17% +$131K
CB
18
DELISTED
CHUBB CORPORATION
CB
$908K 3%
9,395
AON icon
19
Aon
AON
$76.5B
$898K 2.96%
10,705
KMB icon
20
Kimberly-Clark
KMB
$36.3B
$833K 2.75%
8,316
CVX icon
21
Chevron
CVX
$392B
$823K 2.72%
6,585
+500
+8% +$60.4K
GE icon
22
GE Aerospace
GE
$374B
$819K 2.7%
6,097
+59
+1% +$7.43K
BMY icon
23
Bristol-Myers Squibb
BMY
$133B
$809K 2.67%
15,230
-200
-1% -$10.2K
TEVA icon
24
Teva Pharmaceuticals
TEVA
$40.8B
$758K 2.5%
18,910
-245
-1% -$9.65K
MRK icon
25
Merck
MRK
$322B
$690K 2.28%
14,452
+943
+7% +$43.1K

Similar funds

Needelman Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Needelman Asset Management held 38 positions worth $30.3M, up 8.6% from $27.9M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Needelman Asset Management's Q4 2013 filing shows 1 new, 12 increased, 10 reduced and 1 closed positions. Its largest new stake was Markel Group: 1,875 shares worth $1.09M. The largest sale was Vodafone, an estimated $1.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Needelman Asset Management's largest Q4 2013 buy was Markel Group: 1,875 shares worth $1.09M.
  • Needelman Asset Management added most to Pfizer in Q4 2013, an estimated $239K increase.
  • Needelman Asset Management's biggest Q4 2013 reduction was Energy Transfer Partners L.p., cutting an estimated $395K.
  • Needelman Asset Management fully exited Vodafone in Q4 2013, selling an estimated $1.1M.
  • Needelman Asset Management's ten largest holdings make up 36% of its $30.3M portfolio in Q4 2013.
  • Needelman Asset Management opened 1 new position and closed 1 in Q4 2013.
  • Needelman Asset Management's portfolio value rose 8.6% quarter-over-quarter to $30.3M.

Based on Needelman Asset Management's 13F filing for Q4 2013, filed 10 Jan 2014.